Influence of diabetes on peripheral bone mineral density in men: a controlled study

被引:67
作者
Bridges, MJ
Moochhala, SH
Barbour, J
Kelly, CA
机构
[1] N Tees Univ Hosp, Dept Rheumatol, Stockton On Tees TS19 8PE, Teesside, England
[2] Queen Elizabeth Hosp, Dept Endocrinol, Gateshead, Tyne & Wear, England
[3] Queen Elizabeth Hosp, Dept Med, Gateshead, Tyne & Wear, England
关键词
diabetes mellitus; bone mineral density; DEXA; males;
D O I
10.1007/s00592-005-0183-1
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
The aims of the study were to (1) compare peripheral bone mineral density (BMD) in men with diabetes to peripheral BMD in non-diabetic men, and (2) explore factors which may predict BMD in diabetic men. Ninety men with type 2 diabetes and 35 men with type 1 diabetes were randomly selected for participation via a computerised database. Fifty healthy males were also recruited. All patients had peripheral BMD measured by dual energy Xray absorptiometry (DEXA) at the non-dominant distal radius. Information on a number of clinical parameters was obtained by direct questioning, and from patient case notes. The mean age (95% confidence interval (CI)) of the type 1 diabetic group, type 2 diabetic group and control group were, respectively: 49.3 years (44.6-53.9), 62.8 years (60.7-64.8) and 38.5 (34.9-42.1) years. Median (95% CI) Z-scores for the three groups were: -0.18 (-0.68 to +0.32), +0.19 (-0.14 to +0.49) and -0.02 (-0.4 to +0.31), respectively (p=not significant). Only body mass index (BMI) was correlated with BMD in the type 1 diabetic group, and only BMI and age were correlated with BMD in type 2 diabetics. There was no correlation between BMD and glycosylated haemoglobin concentration (HbA(1)c), disease duration or presence of microvascular or macrovascular complications in either of the diabetic groups. We did not find any significant difference in peripheral BMD between patients with type 1 diabetes, type 2 diabetes and controls.
引用
收藏
页码:82 / 86
页数:5
相关论文
共 32 条
[1]
ANDROGEN PLASMA-LEVELS IN MALE DIABETICS [J].
ANDO, S ;
RUBENS, R ;
ROTTIERS, R .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1984, 7 (01) :21-24
[2]
BARRETTCONNOR E, 1992, JAMA-J AM MED ASSOC, V268, P3333
[3]
Forearm bone mineral densitometry cannot be used to monitor response to alendronate therapy in postmenopausal women [J].
Bouxsein, ML ;
Parker, RA ;
Greenspan, SL .
OSTEOPOROSIS INTERNATIONAL, 1999, 10 (06) :505-509
[4]
Osteoporosis and osteopenia in adults and adolescents with cystic fibrosis: prevalence and associated factors [J].
Conway, SP ;
Morton, AM ;
Oldroyd, B ;
Truscott, JG ;
White, H ;
Smith, AH ;
Haigh, I .
THORAX, 2000, 55 (09) :798-804
[5]
A single bone density measurement can predict fractures over 25 years [J].
Duppe, H ;
Gardsell, P ;
Nilsson, B .
CALCIFIED TISSUE INTERNATIONAL, 1997, 60 (02) :171-174
[6]
El Miedany YM, 1999, CLIN EXP RHEUMATOL, V17, P561
[7]
BMD and airways disease [J].
Elmer, C ;
Bartholemew, P ;
Lapworth, A ;
Turner, P ;
Kelly, C .
THORAX, 2002, 57 (02) :186-186
[8]
PERIPHERAL OSTEOPENIA IN ADULT PATIENTS WITH INSULIN-DEPENDENT DIABETES-MELLITUS [J].
FORST, T ;
PFUTZNER, A ;
KANN, P ;
SCHEHLER, B ;
LOBMANN, R ;
SCHAFER, H ;
ANDREAS, J ;
BOCKISCH, A ;
BEYER, J .
DIABETIC MEDICINE, 1995, 12 (10) :874-879
[9]
AN EVALUATION OF BONE-DENSITY AND TURNOVER IN PREMENOPAUSAL WOMEN WITH TYPE-1 DIABETES-MELLITUS [J].
GALLACHER, SJ ;
FENNER, JAK ;
FISHER, BM ;
QUIN, JD ;
FRASER, WD ;
LOGUE, FC ;
COWAN, RA ;
BOYLE, IT ;
MACCUISH, AC .
DIABETIC MEDICINE, 1993, 10 (02) :129-133
[10]
OSTEOPENIA ASSOCIATED WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS - WHAT ARE THE CAUSES [J].
GREGORIO, F ;
CRISTALLINI, S ;
SANTEUSANIO, F ;
FILIPPONI, P ;
FUMELLI, P .
DIABETES RESEARCH AND CLINICAL PRACTICE, 1994, 23 (01) :43-54